2009 ASH Visitor Training Program to build hematologic capacity in developing countries

The American Society of Hematology (ASH) is proud to announce the participants in the 2009 ASH Visitor Training Program, which builds hematologic capacity in developing countries. Through this program, hematologists and medical professionals from developing countries receive valuable clinical, laboratory, or technological training on a specific topic at a host institution under the mentorship of an ASH member anywhere in the world. Upon completion, participants return to their home countries to implement their training and share their newfound knowledge with their colleagues.

"The Visitor Training Program affords promising physicians from developing countries the opportunity to learn about procedures and techniques that are often unavailable in their local medical facilities," said Dr. Nancy Berliner, ASH President. "Our intention is to foster skills and expertise that participants can bring back to their home institutions. This should have a direct, positive impact on the quality of health care in their communities."

This program is part of ASH's larger effort to address hematology-related needs in research, practice, and training in developing areas. Participants are given the opportunity to spend up to 12 weeks at their host institution before returning home to apply their training.

Source: American Society of Hematology

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Early detection of aggressive multiple myeloma through molecular analysis